Literature DB >> 15579456

Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.

Shojiro Kitajima1, Yasusei Kudo, Ikuko Ogawa, Tarig Bashir, Masae Kitagawa, Mutsumi Miyauchi, Michele Pagano, Takashi Takata.   

Abstract

Down-regulation of p27 is frequently observed in various cancers due to an enhancement of its degradation. Skp2 is required for the ubiquitination and consequent degradation of p27 protein. Another protein called Cks1 is also required for p27 ubiquitination in the SCF(Skp2) ubiquitinating machinery. In the present study, we examined Cks1 expression and its correlation with p27 in oral squamous cell carcinoma (OSCC) derived from tongue and gingiva. By immunohistochemical analysis, high expression of Cks1 was present in 62% of OSCCs in comparison with 0% of normal mucosae. In addition, 65% of samples with low p27 expression displayed high Cks1 levels. Finally, Cks1 expression was well correlated with Skp2 expression and poor prognosis. To study the role of Cks1 overexpression in p27 down-regulation, we transfected Cks1 with or without Skp2 into OSCC cells. Cks1 transfection could not induce a p27 down-regulation by itself, but both Cks1 and Skp2 transfection strongly induced. Moreover, we inhibited Cks1 expression by small interference RNA (siRNA) in OSCC. Cks1 siRNA transfection induced p27 accumulation and inhibited the growth of OSCC cells. These findings suggest that Cks1 overexpression may play an important role for OSCC development through Skp2-mediated p27 degradation, and that Cks1 siRNA can be a novel modality of gene therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579456      PMCID: PMC1618711          DOI: 10.1016/S0002-9440(10)63264-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.

Authors:  C Spruck; H Strohmaier; M Watson; A P Smith; A Ryan; T W Krek; S I Reed
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

2.  p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells.

Authors:  H Sutterlüty; E Chatelain; A Marti; C Wirbelauer; M Senften; U Müller; W Krek
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

3.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

Authors:  M Loda; B Cukor; S W Tam; P Lavin; M Fiorentino; G F Draetta; J M Jessup; M Pagano
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

Review 4.  p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer.

Authors:  J Philipp-Staheli; S R Payne; C J Kemp
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

5.  The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27.

Authors:  D Ganoth; G Bornstein; T K Ko; B Larsen; M Tyers; M Pagano; A Hershko
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

6.  Skp2 is oncogenic and overexpressed in human cancers.

Authors:  M Gstaiger; R Jordan; M Lim; C Catzavelos; J Mestan; J Slingerland; W Krek
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

7.  Role of the F-box protein Skp2 in lymphomagenesis.

Authors:  E Latres; R Chiarle; B A Schulman; N P Pavletich; A Pellicer; G Inghirami; M Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

8.  Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas.

Authors:  D Hershko; G Bornstein; O Ben-Izhak; A Carrano; M Pagano; M M Krausz; A Hershko
Journal:  Cancer       Date:  2001-05-01       Impact factor: 6.860

Review 9.  Regulation of the cdk inhibitor p27 and its deregulation in cancer.

Authors:  J Slingerland; M Pagano
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

10.  High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.

Authors:  Y Kudo; S Kitajima; S Sato; M Miyauchi; I Ogawa; T Takata
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

View more
  25 in total

1.  NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma.

Authors:  Junwei Huang; Yi Zhou; Gregory S Thomas; Zhimin Gu; Ye Yang; Hongwei Xu; Guido Tricot; Fenghuang Zhan
Journal:  Clin Cancer Res       Date:  2015-07-08       Impact factor: 12.531

2.  Cks1 enhances transcription efficiency at the GAL1 locus by linking the Paf1 complex to the 19S proteasome.

Authors:  Yen-Ru Pan; Michael Sun; James Wohlschlegel; Steven I Reed
Journal:  Eukaryot Cell       Date:  2013-07-03

3.  CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.

Authors:  Fenghuang Zhan; Simona Colla; Xiaosong Wu; Bangzheng Chen; James P Stewart; W Michael Kuehl; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2007-02-15       Impact factor: 22.113

4.  Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells.

Authors:  Ja-Yeon Kim; Hong Joo Kim; Jung Ho Park; Dong Il Park; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Dong Hoon Kim; Seoung Wan Chae; Jin Hee Sohn
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

5.  Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells.

Authors:  Hanna-Stina Martinsson-Ahlzén; Vasco Liberal; Björn Grünenfelder; Susana R Chaves; Charles H Spruck; Steven I Reed
Journal:  Mol Cell Biol       Date:  2008-07-14       Impact factor: 4.272

6.  Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death.

Authors:  Yongsheng Lan; Yongyou Zhang; Jianghua Wang; Chunhong Lin; Michael M Ittmann; Fen Wang
Journal:  Int J Cancer       Date:  2008-08-01       Impact factor: 7.396

7.  Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.

Authors:  Anupriya Agarwal; Thomas G P Bumm; Amie S Corbin; Thomas O'Hare; Marc Loriaux; Jonathan VanDyke; Stephanie G Willis; Jutta Deininger; Keiichi I Nakayama; Brian J Druker; Michael W Deininger
Journal:  Blood       Date:  2008-06-17       Impact factor: 22.113

8.  The APC/C recruits cyclin B1-Cdk1-Cks in prometaphase before D box recognition to control mitotic exit.

Authors:  Wouter van Zon; Janneke Ogink; Bas ter Riet; René H Medema; Hein te Riele; Rob M F Wolthuis
Journal:  J Cell Biol       Date:  2010-08-23       Impact factor: 10.539

9.  Information theoretical quantification of cooperativity in signalling complexes.

Authors:  Tom Lenaerts; Jesper Ferkinghoff-Borg; Joost Schymkowitz; Frederic Rousseau
Journal:  BMC Syst Biol       Date:  2009-01-16

Review 10.  Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors:  David Frescas; Michele Pagano
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.